S'abonner

Endoscopy of the upper gastrointestinal tract as a diagnostic tool for children with human immunodeficiency virus infection - 11/09/11

Doi : 10.1016/S0022-3476(97)80020-0 
Tracie L. Miller, MD a, b, , Linda B. McQuinn, SM a, b, E. John Orav, PhD a, b
a From the Combined Program in Pediatric Gastroenterology and Nutrition, Children's Hospital, Boston, Massachusetts, USA 
b the Department of Pediatrics, Harvard School of Public Health, Harvard Medical School, Boston, Massachusetts, USA 

Reprint requests: Tracie L. Miller, MD, Gastroenterology and Nutrition, Box 667, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642.

Abstract

Objective: The purpose of this study was to determine the prevalence of upper gastrointestinal tract lesions in children with human immunodeficiency virus (HIV) infection who undergo endoscopy of the upper gastrointestinal tract and to identify important clinical predictors of abnormal endoscopic results.

Methods: All HIV-infected children who underwent endoscopy and were followed at Children's Hospital, Boston, from January 1985 to August 1994 were studied. The main outcome measure was endoscopic results, which were categorized into observational, histologic, and microbiologic findings. Potential predictors included height, weight, nutritional interventions, HIV disease stage, CD4 T-lymphocyte count, medications, active infections, and indications for endoscopy.

Results: Forty-three endoscopies in unique patients are reported. Most children had advanced HIV infection (67% acquired immunodeficiency syndrome, mean CD4 T-lymphocyte count z score=−2.71, weight z score=−2.04). An abnormal endoscopic finding was discovered in 93% of children and confirmed by histologic, microbiologic, or a combination of these studies in 72% of children. Thirty-five percent of children had an opportunistic pathogen identified endoscopically; 65% of these pathogens were previusly undiagnosed. Observational findings often were poor indicators of histologic and microbiologic abnormalities. Independent predictors of abnormal histologic findings include younger age at endoscopy (odds ratio (OR)=1.16 per year, 95% confidence interval (Cl) (1.02, 1.33)) and guaiac-negative stools (OR=16.7, 95% Cl (1.92, 142.9)). Independent predictors of finding a pathogen at the time of endoscopy include a greater number of indications for endoscopy (OR=2.6 per indication, 95% Cl (1.3, 5.3)) and diagnosis of acquired immunodeficiency syndrome (OR=16.4, 95% Cl (1.3, 213)). No other gastrointestinal, nutritional, or immunologic parameters were significantly predictive of endoscopic outcomes. Medical management was changed in 70% of children because of the endoscopic findings.

Conclusion: Endoscopy is a useful tool to direct therapy against peptic and infectious disorders of the upper gastrointestinal tract in children with HIV infection. Specific gastrointestinal symptoms are not useful predictors of abnormal results.

Le texte complet de cet article est disponible en PDF.

Abbreviations : AIDS, CI, HIV, OR


Plan


* Supported in part by National Institute of Health grants No. F32DK08518, P0145734, and 5M01RR02172; a Charles H. Hood Foundation Award; a Scholar Award from the Pediatric AIDS Foundation, a Student Intern Award from the Pediatric AIDS Foundation; and a Glaxo Clinical Research Award.


© 1997  Mosby-Year Book, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 130 - N° 5

P. 766-773 - mai 1997 Retour au numéro
Article précédent Article précédent
  • Community impact of childhood varicella infections
  • Barbara P. Yawn, Roy A. Yawn, Eva Lydick
| Article suivant Article suivant
  • Epidemiologic study of Langerhans cell histiocytosis in children
  • Smita Bhatia, Mark E. Nesbit, Maarten Egeler, Jonathan D. Buckley, Ann Mertens, Leslie L. Robison

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.